CURE CF INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

JOSEPH KLAUSING

Phone

5024199099

Tax Period

2024-01-01 to 2024-12-31

CURE CF INC, founded in 2015, is a micro nonprofit in the Diseases & Disorders sector that reported $20K in total revenue in fiscal year 2024. Revenue fell 85% from the prior year — a significant decline worth monitoring. Expenses of $175K exceeded revenue, resulting in a 792% operating deficit.

Mission

RAISE FUNDS FOR RESEARCH TO CURE CYSTIC FIBROSIS

Program Service Accomplishments

Program 1

Expenses: $3,778 Revenue: $19,624

CURE CF HOSTS EVENTS FROM TIME TO TIME WITH THE PURPOSE OF RAISING FUNDS TO DONATE TO CYSTIC FIBROSIS RESEARCH. NO EVENTS WERE HELD DURING 2024. IT ACCEPTS DONATIONS WHICH RAISE SMALLER TOTALS. ALL...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $19,624

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $19,624

Expense Breakdown

Grants Paid $171,268

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $171,268

Other Expenses $3,778

TOTAL EXPENSES $175,046

Year-over-Year Comparison

	2024	2023	Change
Revenue	$19,624	$126,620	-0.8%
Expenses	$175,046	$13,013	+12.5%
Net Income	$-155,422	$113,607	-2.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

N/A

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOSEPH KLAUSING	DIRECTOR	3.00	Director	$0	$0	$0
COURTNEY HERZOG	DIRECTOR	3.00	Director	$0	$0	$0
JESSICA KLAUSING	DIRECTOR	3.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$19,624	$175,046	$285,630	$-155,422
2023	$126,620	$13,013	$441,052	$113,607
2022	$244,751	$116,964	$327,445	$127,787
2021	$239,849	$149,205	$199,657	$90,644
2020	$216,810	$303,861	$109,371	$-87,051
2019	$303,750	$312,346	$196,010	$-8,596
2018	$319,963	$136,992	$206,014	$182,971